Since 1977 deaths registered as being due to haemolytic disease of the newborn in England and Wales have been analysed in an attemptto discover the circumstances in which each mother became immunised and also to assess the accuracy of certification of deaths. Results from 1977 to 1983 have been published previously'; we describe here results up to 1985.
Methods and results
Cases Rh grouping errors (three), pregnancy terminated before the 30th week and treatment with anti-Rh believed to be unnecessary (10 (eight before 15th week)), full term delivery (reasons for "not given anti-Rh" unknown) (five).
Whereas there was a substantial fall in the numbers of cases in category 1, the number of deaths in the offspring of women immunised during their first pregnancy (category 2) or who became immunised despite having been given anti-Rh after their first delivery (category 3) showed very little fall in 1977-85, perhaps surprisingly in view of advances in the treatment of haemolytic disease.
Deaths from haemolytic disease due to antibodies other than anti-D (category 5) also remained roughly constant. In 1977-85 there were about four such cases a year; the antibodies concerned were anti-c -E (23), -K (eight), -c+ -K (two), -C (one).
The numbers of deaths registered as being due to haemolytic disease but judged on inspection of death certificates and hospital notes not to have been so (category 6) fell strikingly. One of the remaining relatively common causes of false certification is failure to realise that hydrops fetalis may be nonimmunological, often associated with congenital abnormalities.2
Comment
Our Our data suggest that many women become immunised because they are not given anti-Rh immunoglobulin after an abortion. Even more important is the finding that in about half the mothers whose infants died in 1984 and 1985 Rh immunisation could have been prevented only by antenatal treatment. The introduction of antenatal immunoprophylaxis combined with recent advances in treating the affected infant4 should eventually reduce mortality from this disease to a very low level.
